These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 28902450)

  • 1. Current status of portal vein thrombosis in Japan: Results of a questionnaire survey by the Japan Society for Portal Hypertension.
    Kojima S; Watanabe N; Koizumi J; Kokubu S; Murashima N; Matsutani S; Obara K
    Hepatol Res; 2018 Mar; 48(4):244-254. PubMed ID: 28902450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Portal vein thrombosis in liver cirrhosis: incidence, management, and outcome.
    Fujiyama S; Saitoh S; Kawamura Y; Sezaki H; Hosaka T; Akuta N; Kobayashi M; Suzuki Y; Suzuki F; Arase Y; Ikeda K; Kumada H
    BMC Gastroenterol; 2017 Oct; 17(1):112. PubMed ID: 29070023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Danaparoid sodium-based anticoagulation therapy for portal vein thrombosis in cirrhosis patients.
    Hayashi T; Takatori H; Horii R; Nio K; Terashima T; Iida N; Kitahara M; Shimakami T; Arai K; Kitamura K; Kawaguchi K; Yamashita T; Sakai Y; Yamashita T; Mizukoshi E; Honda M; Toyama T; Okumura K; Kozaka K; Kaneko S
    BMC Gastroenterol; 2019 Dec; 19(1):217. PubMed ID: 31842768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis.
    Noronha Ferreira C; Reis D; Cortez-Pinto H; Tato Marinho R; Gonçalves A; Palma S; Leite I; Rodrigues T; Pedro AJ; Alexandrino P; Serejo F; Sobral Dias M; Ferreira P; Vasconcelos M; Damião F; Xavier Brito L; Baldaia C; Fatela N; Ramalho F; Velosa J
    Dig Dis Sci; 2019 Sep; 64(9):2671-2683. PubMed ID: 30852769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing risk stratification in portal vein thrombosis after splenectomy and its primary prophylaxis with antithrombin III concentrates and danaparoid sodium in liver cirrhosis with portal hypertension.
    Kawanaka H; Akahoshi T; Itoh S; Iguchi T; Harimoto N; Uchiyama H; Yoshizumi T; Shirabe K; Takenaka K; Maehara Y
    J Am Coll Surg; 2014 Nov; 219(5):865-74. PubMed ID: 25256370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Portal vein thrombosis in cirrhosis.
    Raja K; Jacob M; Asthana S
    J Clin Exp Hepatol; 2014 Dec; 4(4):320-31. PubMed ID: 25755579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical features of liver cirrhosis complicated by portal vein thrombosis and related risk factors].
    Lin GS; Xu Q; Zhao SY; Zhang YX
    Zhonghua Gan Zang Bing Za Zhi; 2016 Jul; 24(7):513-517. PubMed ID: 27784429
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy and safety of the anticoagulant drug, danaparoid sodium, in the treatment of portal vein thrombosis in patients with liver cirrhosis.
    Naeshiro N; Aikata H; Hyogo H; Kan H; Fujino H; Kobayashi T; Fukuhara T; Honda Y; Nakahara T; Ohno A; Miyaki D; Murakami E; Kawaoka T; Tsuge M; Hiraga N; Hiramatsu A; Imamura M; Kawakami Y; Ochi H; Chayama K
    Hepatol Res; 2015 Jun; 45(6):656-62. PubMed ID: 25088236
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors associated with portal vein thrombosis in liver cirrhosis: A case-control study.
    Nadinskaia MY; Kodzoeva KB; Ulyanova KA; Volkova AS; Rogacheva SI; Dekhanov AS; Strelkova DA; Ivashkin VT
    Ter Arkh; 2019 Mar; 91(2):73-81. PubMed ID: 31094175
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of portal vein thrombosis in liver cirrhosis.
    Qi X; Han G; Fan D
    Nat Rev Gastroenterol Hepatol; 2014 Jul; 11(7):435-46. PubMed ID: 24686266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nonsurgical Therapeutic Options in Portal Vein Thrombosis.
    Schultheiß M; Bettinger D; Thimme R
    Viszeralmedizin; 2014 Dec; 30(6):388-92. PubMed ID: 26288606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of Thrombosis Volume, Anticoagulants, and Recurrence Factors in Portal Vein Thrombosis with Cirrhosis.
    Suda T; Takatori H; Hayashi T; Horii R; Nio K; Terashima T; Iida N; Kitahara M; Shimakami T; Arai K; Yamashita T; Yamashita T; Mizukoshi E; Honda M; Okumura K; Kozaka K; Kaneko S
    Life (Basel); 2020 Sep; 10(9):. PubMed ID: 32899804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Preoperative risk factors of portal venous thrombosis after splenectomy and gastric pericardial devascularization for portal hypertension].
    Han J; Yi Y; Ding H; Liu J; Zhang Y; Hu L; Zhao L; Liu T
    Zhonghua Gan Zang Bing Za Zhi; 2014 Oct; 22(10):739-43. PubMed ID: 25496862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transjugular intrahepatic portosystemic shunt for portal vein thrombosis with symptomatic portal hypertension in liver cirrhosis.
    Han G; Qi X; He C; Yin Z; Wang J; Xia J; Yang Z; Bai M; Meng X; Niu J; Wu K; Fan D
    J Hepatol; 2011 Jan; 54(1):78-88. PubMed ID: 20932597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis.
    Amitrano L; Guardascione MA; Brancaccio V; Margaglione M; Manguso F; Iannaccone L; Grandone E; Balzano A
    J Hepatol; 2004 May; 40(5):736-41. PubMed ID: 15094219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of edoxaban for treatment of portal vein thrombosis following danaparoid sodium in patients with liver cirrhosis.
    Nagaoki Y; Aikata H; Daijyo K; Teraoka Y; Shinohara F; Nakamura Y; Hatooka M; Morio K; Nakahara T; Kawaoka T; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Ochi H; Chayama K
    Hepatol Res; 2018 Jan; 48(1):51-58. PubMed ID: 28342265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Preclinical Porcine Model of Portal Vein Thrombosis in Liver Cirrhosis.
    Zhang R; Lu S; Jiang YY; Ma JQ; Zhang W; Gu JY; Wang J; Chen SY
    Biomed Res Int; 2020; 2020():3086906. PubMed ID: 32351989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Harmful and Beneficial Effects of Anticoagulants in Patients With Cirrhosis and Portal Vein Thrombosis.
    La Mura V; Braham S; Tosetti G; Branchi F; Bitto N; Moia M; Fracanzani AL; Colombo M; Tripodi A; Primignani M
    Clin Gastroenterol Hepatol; 2018 Jul; 16(7):1146-1152.e4. PubMed ID: 29066371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The use of nonselective beta blockers is a risk factor for portal vein thrombosis in cirrhotic patients.
    Zampino R; Lebano R; Coppola N; Macera M; Grandone A; Rinaldi L; De Sio I; Tufano A; Stornaiuolo G; Adinolfi LE; Durante-Mangoni E; Battista GG; Niglio A
    Saudi J Gastroenterol; 2018; 24(1):25-29. PubMed ID: 29451181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome.
    Yerdel MA; Gunson B; Mirza D; Karayalçin K; Olliff S; Buckels J; Mayer D; McMaster P; Pirenne J
    Transplantation; 2000 May; 69(9):1873-81. PubMed ID: 10830225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.